BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15063915)

  • 1. Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity.
    Timko C; Sempel JM
    J Subst Abuse Treat; 2004 Apr; 26(3):209-18. PubMed ID: 15063915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
    Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
    Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
    Timko C; Dixon K; Moos RH
    Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes.
    Ouimette PC; Gima K; Moos RH; Finney JW
    Alcohol Clin Exp Res; 1999 Mar; 23(3):552-7. PubMed ID: 10195832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual diagnosis in an Australian forensic psychiatric hospital: prevalence and implications for services.
    Ogloff JR; Lemphers A; Dwyer C
    Behav Sci Law; 2004; 22(4):543-62. PubMed ID: 15282839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care.
    Stahler GJ; Mennis J; Cotlar R; Baron DA
    Am J Psychiatry; 2009 Nov; 166(11):1258-68. PubMed ID: 19797433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative evaluation of substance abuse treatment: I. Treatment orientation, amount of care, and 1-year outcomes.
    Moos RH; Finney JW; Ouimette PC; Suchinsky RT
    Alcohol Clin Exp Res; 1999 Mar; 23(3):529-36. PubMed ID: 10195829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorder treatment programs in Switzerland and the USA: Program characteristics and 1-year outcomes.
    Moggi F; Giovanoli A; Strik W; Moos BS; Moos RH
    Drug Alcohol Depend; 2007 Jan; 86(1):75-83. PubMed ID: 16782286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of substance abuse treatment: V. Substance abuse treatment can enhance the effectiveness of self-help groups.
    Humphreys K; Huebsch PD; Finney JW; Moos RH
    Alcohol Clin Exp Res; 1999 Mar; 23(3):558-63. PubMed ID: 10195833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturalistic comparison of models of programmatic interventions for combat-related post-traumatic stress disorder.
    Forbes D; Lewis V; Parslow R; Hawthorne G; Creamer M
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1051-9. PubMed ID: 19016093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of individual, program, and neighborhood variables on continuity of treatment among dually diagnosed individuals.
    Stahler GJ; Mazzella S; Mennis J; Chakravorty S; Rengert G; Spiga R
    Drug Alcohol Depend; 2007 Feb; 87(1):54-62. PubMed ID: 16962255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based psychodynamic treatment program for severe personality disorders: clinical description and naturalistic evaluation.
    Chiesa M; Fonagy P; Gordon J
    J Psychiatr Pract; 2009 Jan; 15(1):12-24. PubMed ID: 19182561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
    Brunette MF; Mueser KT
    J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance-induced suicidal admissions to an acute psychiatric service: characteristics and outcomes.
    Ries RK; Yuodelis-Flores C; Comtois KA; Roy-Byrne PP; Russo JE
    J Subst Abuse Treat; 2008 Jan; 34(1):72-9. PubMed ID: 17574802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of planned discharge from case management: a 3 year retrospective study.
    Backus L; Weinkove J; Lucas M; Jespersen S
    Australas Psychiatry; 2008 Feb; 16(1):33-8. PubMed ID: 17957526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.